| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |